Attached files
| file | filename |
|---|---|
| S-1/A - FORM S-1/A PRE-EFFECTIVE AMENDMENT NO. 2 - Midatech Pharma US Inc. | d303308ds1a.htm |
| EX-3.5 - FORM OF CERTIFICATE OF DESIGNATION - Midatech Pharma US Inc. | d303308dex35.htm |
| EX-4.18 - FORM OF INDENTURE - Midatech Pharma US Inc. | d303308dex418.htm |
| EX-10.38 - FORM OF SECURIITIES PURCHASE AGREEMENT - Midatech Pharma US Inc. | d303308dex1038.htm |
| EX-10.37 - FORM OF PLACEMENT - Midatech Pharma US Inc. | d303308dex1037.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Pre-Effective Amendment No. 2 to the Registration Statement (Form S-1 No. 333-179637) and related Prospectus of DARA BioSciences, Inc. for the registration of shares of its preferred and common stock and warrants and to the incorporation by reference therein of our report dated February 17, 2012 with respect to the consolidated financial statements of DARA BioSciences, Inc. and subsidiaries included in its Annual Report (Form 10-K) for the year ended December 31, 2011, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Ernst & Young LLP
Raleigh, North Carolina
March 23, 2012